Lisa Öberg

Mx. Lisa Öberg

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2019 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SKSiew-Kim Khoo
Siew-Kim Khoo
JRJames Read
James Read
KFKimberley Franks
Kimberley Franks
GZGuicheng Zhang
Guicheng Zhang
JBJoelene Bizzintino
Joelene Bizzintino
ABAnthony Bosco
Anthony Bosco
Asthma exacerbations are triggered by rhinovirus infections. We employed a systems biology approach to delineate upper-airway gene network patterns underlying asthma exacerbation phenotypes in children. Cluster analysis unveiled distinct IRF7hi versus IRF7lo molecular phenotypes, the former exhibiting robust upregulation of Th1/type I IFN responses and the latter an alternative signature marked by upregulation of cytokine and growth factor signaling and downregulation of IFN-γ. The two phenotypes also produced distinct clinical phenotypes. For IRF7lo children, symptom duration prior to hospital presentation was more than twice as long from initial symptoms (p = 0.011) and nearly three times as long for cough (p < 0.001), the odds ratio of admission to hospital was increased more than 4-fold (p = 0.018), and time to recurrence was shorter (p = 0.015). In summary, our findings demonstrate that asthma exacerbations in children can be divided into IRF7hi versus IRF7lo phenotypes with associated differences in clinical phenotypes.

22 February 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
UHUlf Hedström
Ulf Hedström
OHOskar Hallgren
Oskar Hallgren
LÖLisa Öberg
Lisa Öberg
ADAmy DeMicco
Amy DeMicco
OVOuti Vaarala
Outi Vaarala
XZXiaohong Zhou
Xiaohong Zhou
Chronic obstructive pulmonary disease (COPD) is a serious global health problem characterized by chronic airway inflammation, progressive airflow limitation and destruction of lung parenchyma. Remodeling of the bronchial airways in COPD includes changes in both the bronchial epithelium and the subepithelial extracellular matrix (ECM). To explore the impact of an aberrant ECM on epithelial cell phenotype in COPD we developed a new ex vivo model, in which normal human bronchial epithelial (NHBE) cells repopulate and differentiate on decellularized human bronchial scaffolds derived from COPD patients and healthy individuals. By using transcriptomics, we show that bronchial ECM from COPD patients induces differential gene expression in primary NHBE cells when compared to normal bronchial ECM. The gene expression profile indicated altered activity of upstream mediators associated with COPD pathophysiology, including hepatocyte growth factor, transforming growth factor beta 1 and platelet-derived growth factor B, which suggests that COPD-related changes in the bronchial ECM contribute to the defective regenerative ability in the airways of COPD patients.

1 December 2022 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
VHVentzislava A. Hristova
Ventzislava A. Hristova
AWAlastair Watson
Alastair Watson
RCRaghothama Chaerkady
Raghothama Chaerkady
MGMatthew S. Glover
Matthew S. Glover
JAJodie Ackland
Jodie Ackland
OGon behalf of the MICA II Study group
on behalf of the MICA II Study group
Rationale: Pulmonary surfactant is vital for lung homeostasis as it reduces surface tension to prevent alveolar collapse and provides essential immune-regulatory and antipathogenic functions. Previous studies demonstrated dysregulation of some individual surfactant components in COPD. We investigated relationships between COPD disease measures and dysregulation of surfactant components to gain new insights into potential disease mechanisms.Methods: Bronchoalveolar lavage proteome and lipidome were characterised in ex-smoking mild/moderate COPD subjects (n=26) and healthy ex-smoking (n=20) and never-smoking (n=16) controls using mass spectrometry. Serum surfactant protein analysis was performed.Results: Total phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol, surfactant protein (SP)-B, SP-A and SP-D concentrations were lower in COPDversuscontrols (log2fold change (log2FC) −2.0, −2.2, −1.5, −0.5, −0.7 and −0.5 (adjusted p<0.02), respectively) and correlated with lung function. Total phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol, SP-A, SP-B, SP-D, napsin A and CD44 inversely correlated with computed tomography small airways disease measures (expiratory to inspiratory mean lung density) (r= −0.56, r= −0.58, r= −0.45, r= −0.36, r= −0.44, r= −0.37, r= −0.40 and r= −0.39 (adjusted p<0.05)). Total phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol, SP-A, SP-B, SP-D and NAPSA inversely correlated with emphysema (% low-attenuation areas): r= −0.55, r= −0.61, r= −0.48, r= −0.51, r= −0.41, r= −0.31 and r= −0.34, respectively (adjusted p<0.05). Neutrophil elastase, known to degrade SP-A and SP-D, was elevated in COPDversuscontrols (log2FC 0.40, adjusted p=0.0390), and inversely correlated with SP-A and SP-D. Serum SP-D was increased in COPDversushealthy ex-smoking volunteers, and predicted COPD status (area under the curve 0.85).Conclusions: Using a multiomics approach, we demonstrate, for the first time, global surfactant dysregulation in COPD that was associated with emphysema, giving new insights into potential mechanisms underlying the cause or consequence of disease.

1 November 2019 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
NKNisha Kurian
Nisha Kurian
TCTaylor Cohen
Taylor Cohen
LÖLisa Öberg
Lisa Öberg
EZErica De Zan
Erica De Zan
GSGabriel Skogberg
Gabriel Skogberg
DCDanen M Cunoosamy
Danen M Cunoosamy
Background: Unlike p38 mitogen-activated protein Kinases (MAPK) that has been extensively studied in the context of lung-associated pathologies in COPD, the role of the dual-specificity mitogen-activated protein kinase kinase (MEK1/2) or its downstream signaling molecule extracellular signal-regulated kinases 1/2 (ERK1/2) in COPD is poorly understood. Objectives: The aim of this study was to address whether MEK1/2 pathway activation is linked to COPD and that targeting this pathway can improve lung inflammation through decreased immune-mediated inflammatory responses without compromising bacterial clearance. Methods: Association of MEK1/2 pathway activation to COPD was investigated by immunohistochemistry using lung tissue biopsies from COPD and healthy individuals and through analysis of sputum gene expression data from COPD patients. The anti-inflammatory effect of MEK1/2 inhibition was assessed on cytokine release from lipopolysaccharide-stimulated alveolar macrophages. The effect of MEK1/2 inhibition on bacterial clearance was assessed using Staphylococcus aureus killing assays with RAW 264.7 macrophage cell line and human neutrophils. Results: We report here MEK1/2 pathway activation demonstrated by increased pERK1/2 staining in bronchial epithelium and by the presence of MEK gene activation signature in sputum samples from COPD patients. Inhibition of MEK1/2 resulted in a superior anti-inflammatory effect in human alveolar macrophages in comparison to a p38 inhibitor. Furthermore, MEK1/2 inhibition led to an increase in bacterial killing in human neutrophils and RAW 264.7 cells that was not observed with the p38 inhibitor. Conclusion: Our data demonstrate the activation of MEK1/2 pathway in COPD and highlight a dual function of MEK1/2 inhibition in improving host defense responses whilst also controlling inflammation.

8 February 2024 in EMBO Reports
Verified
Journal Article
Open access
SFSUZANNE FAURE-DUPUY
SUZANNE FAURE-DUPUY
JJJamil Jubrail
Jamil Jubrail
MDManon Depierre
Manon Depierre
KAKshanti Africano-Gomez
Kshanti Africano-Gomez
LÖLisa Öberg
Lisa Öberg
FNFlorence Niedergang
Florence Niedergang
Human rhinovirus is the most frequently isolated virus during severe exacerbations of chronic respiratory diseases, like chronic obstructive pulmonary disease. In this disease, alveolar macrophages display significantly diminished phagocytic functions that could be associated with bacterial superinfections. However, how human rhinovirus affects the functions of macrophages is largely unknown. Macrophages treated with HRV16 demonstrate deficient bacteria-killing activity, impaired phagolysosome biogenesis, and altered intracellular compartments. Using RNA sequencing, we identify the small GTPase ARL5b to be upregulated by the virus in primary human macrophages. Importantly, depletion of ARL5b rescues bacterial clearance and localization of endosomal markers in macrophages upon HRV16 exposure. In permissive cells, depletion of ARL5b increases the secretion of HRV16 virions. Thus, we identify ARL5b as a novel regulator of intracellular trafficking dynamics and phagolysosomal biogenesis in macrophages and as a restriction factor of HRV16 in permissive cells.

1 April 2018 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
ISIgor Shamovsky
Igor Shamovsky
GBGraham Belfield
Graham Belfield
RLRichard J. Lewis
Richard J. Lewis
FNFrank Narjes
Frank Narjes
LRLena Ripa
Lena Ripa
PSPeter Olof Sjö
Peter Olof Sjö